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The study evaluates in vivo antimalarial activity of arteether and garlic pearl oil combination in Plas-
modium berghei-infected mouse model of malaria. 72 h (Day 3) post infection, at 2–4% parasitemia, mice
were treated with single dose intramuscular injection of α-β arteether, at 750 μg, in combination with
three 100 μL oral doses of garlic pearl oil on Day 3, Day 4 and Day 5. Following the treatment, 100%
protection and survival of mice were observed. Inhibition of parasitemia in combination treated animals
and protection during recrudescence interval of α-β arteether monotherapy was observed in Giemsa-
stained blood smears. In addition, a striking increase in anti-parasite antibody IgG contributing protec-
tive immunity during the recrudescence phase was observed. These results correlate with western blot
analysis, where sera from the recrudescence stage and later period of arteether and garlic oil combi-
nation treated animals found to interact with several parasite speciﬁc proteins as compared to controls.
The present approach shows that arteether and garlic pearl oil combination provides complete protection
in P. berghei-infected mice. Thus, for the ﬁrst time, garlic pearl oil appears to be an ideal antimalarial
candidate in artemisinin combination therapy.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Malaria, a mosquito-borne disease caused by protozoa parasites
(a type of unicellular microorganism) of the genus Plasmodium, is
the main cause of mortality in children, pregnant women and
immune depressed people in disease-endemic countries [1]. Ac-
cording to statistics, 60% of malaria death occurs in under-
developed countries [2]. In the last decade, several attempts have
been made to improve the situation by multifaceted approach,
such as discovering and developing new antimalarial drugs, facil-
itating their delivery to remote areas and distributing them at an
affordable price. In spite of these concerted efforts, the success was
less than desired; the reason being development of drug resistance
to monotherapy, high cost of artemisinin-based therapy, lack of
investment for development of anti-parasitic drugs and un-
awareness among the general public about the malaria prevention
and treatment [3]. Thus, need of the hour is improvement in the
therapeutic potential of existing antimalarial drugs by using them
in combination and by developing suitable drug delivery system.
Among these two approaches, to succeed in combination therapy,B.V. This is an open access article u
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cally or additively is of prime importance to (a) prolong the de-
velopment of resistance to antimalarial drugs, (b) reduce the cost
of treatment and (c) stop recrudescence.
Among different types of combination therapies, artemisinin- a
well known antimalarial drug- based combination therapy is the
most preferred one [4]. Artemisinin and its derivatives are essen-
tially sesquiterpene lactone endoperoxides and are potent anti-
malarials [5]. Mechanism of action of artemisinin basically involve
free-radical generation by alkylated heme adducts and proteins
[6]. There's also a view that artemisinins have a speciﬁc target
PfATP6, a SERCA-type calcium-ATPase [7]. Several combinations
with artemisinin derivative have been advocated for their anti-
malarial activity such as artesunateþsulfadoxine-pyrimethamine,
artesunateþmeﬂoquine, dihydroartemisininþpiperaquine and
artemetherþ lumefantrine [8]. However, the existing artemisinin-
based combination therapies have several drawbacks, such as
toxicity, high cost, limited availability of artemisinin and low
bioavailability of artemisinin and its partner drugs [9]. In this re-
gard, we have made an attempt to ﬁnd a suitable partner drug for
arteether, a semi-synthetic derivative of artemisinin, which is
preferred for the treatment of chloroquine-resistant malaria in
most parts of the world [10].
Garlic (Allium sativum), for years, has been widely used as a
medicine to reduce various risk factors associated with severalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Distribution of animals for treatment and treatment protocol (n¼10).
Group Treatment
(Day 3)
Treatment
(Day 4)
Treatment
(Day 5)
Control – – –
G50 G G G
G100 G G G
G150 G G G
AE 750 mg AE – –
AE 1.5 mg AE – –
G50 mLþAE 750 mg AE/G G G
G100 mLþAE 750 mg AE/G G G
G150 mLþAE 750 mg AE/G G G
G: garlic pearl oil; AE: arteether; AE/G: garlic pearl oil and arteether combination
treatment.
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eﬁcial in treatment of cancer, infection, inﬂammation etc. [11]. It is
also known to exhibit anticoagulant, antioxidant, antibiotic, hy-
pocholesterolaemic, hypoglycaemic and hypotensive activities
[12]. The problem, however, is that the biological studies have not
gone hand in hand with the chemical studies, with the frequent
use of garlic products of undeﬁned composition. Very few studies
have used a chemically characterized product [13]. The composi-
tion of garlic depends on the source, age, storage conditions, type
of processing and method of consumption. Unfortunately, the
different forms of garlic are frequently referred to as “garlic” in
both the common and scientiﬁc literature. The amount of main
component of garlic organosulfur compounds vary within the
different strains of garlic, and the problem is compounded by the
volatile and reactive nature of these compounds [14].
Major volatile organosulfur functional compounds present in
garlic oil are alliin, diallyl sulﬁde (DAS), diallyl disulﬁde (DADS),
diallyl trisulﬁde (DATS). Fresh garlic contains mainly alliin, upon
crushing, converted to thiosulﬁnate compound, allicin by alliinase.
The mechanism of action of garlic oil identiﬁed by various studies
include (a) suppressed LDL oxidation for anti-atherosclerotic ef-
fect, (b) inhibition or inactivation of thrombin for anticoagulant
effect (c) arachidonic acid cascade pathway inhibition for anti-
platelet activity (d) ROS mediated cytotoxicity for anticancer ef-
fects [12]. On the other hand, allicin (diallyl thiosulﬁnate) effects
with a wide range of biological activities and has been used for
centuries owing to its therapeutic and health-promoting proper-
ties [15]. Garlic when crushed produces allicin by non-proteino-
genic amino acid alliin (S-allyl cysteine sulfoxide). Allicin, a re-
active sulfur species (RSS) [16] with oxidizing properties, acts via
redox-dependent mechanisms [17], and has wide-ranging and
promising applications in medicine. Allicin acts as an antioxidative
at lower dose in cardiovascular problems at physiological level
[18,19]. It also acts at immune-correlated diseases [20]. The anti-
microbial properties of garlic have been well studied, with studies
being recorded as early as the 1940s [21]. Garlic has also been
shown to have role against plant pathogens [22], pathogenic fungi
[23] and at molecular level in human pathogens [24].
There is a clear necessity for standardization of garlic pre-
parations, especially for use in biological studies. More recent
biological studies have attempted to rectify this problem. Hence,
we have used the ayurvedic medicine garlic pearl oil, locally
available in India which is already in use for management of
cholesterol, hypertension, digestion and to improve immunity.
Garlic pearls are made from extract of concentrated source of a
special variety of garlic. Garlic pearl oil is known for its activity due
to the presence of active compounds like allicin and diallyl sulﬁde
(DAS), which are preserved through a special process by garlic
pearls’ manufacturers. Garlic pearl oil from Ranbaxy India has
been used in several studies such as antioxidant activity in myo-
cardial infarction [25], gastroprotective activity in gastric ulcers
[26], as a supplement for hypertension [27] and also when used in
combination was effective in the correction of dyslipidemia [28].
Studies have also shown that allicin and ajoene, bioactive com-
ponents of garlic, could partially protect mice from malaria in-
fection individually or in combination with other antimalarial
drugs [29,30]. In addition, use of garlic has several other ad-
vantages such as it is non-toxic, easily available in plenty, been
used by humans for 45000 years. Thus, garlic could be an ideal
candidate for antimalarial drug. In this study, we have explored
the novel arteether and garlic pearl oil combination therapy for
malaria treatment.2. Materials and methods
2.1. Drugs and chemicals
Commercially available antimalarial drug α-β arteether (E
MAL™, Themis Medicare Ltd., Mumbai, India) and ayurvedic
medicine garlic pearl oil (Ranbaxy Laboratories Ltd., New Delhi,
India) were procured locally.
2.2. Animals and treatment in mice
Swiss mice (2575 g) were used in the study. They were ob-
tained from the Central Animal Facility, Indian Institute of Science,
Bangalore, India. All precautions were undertaken to minimize
suffering. Animal experiments were carried out as per the guide-
lines of the Committee for the Purpose of Control and Supervision
of Experimental Animals (CPCSEA). The treatment of mice and all
experimental protocols were according to the Institutional Animal
Care and Use Committee guidelines.
To sudy the in vivo antimalarial activity of arteether and garlic
pearl oil either individually or in combination at various dosage
levels, malaria parasite P. berghei-infected blood with 60–70%
parasitemia was collected and injected intraperitoneally into ex-
perimental mice on Day 0 (start of experiment) after appropriate
dilution. All the control mice died between Day 4 and Day 6 post
infection. After 72 h (Day 3), when the parasitemia was about 2–
4%, infected mice were treated with either single dose of arteether
(750 mg or 1.5 mg) intramuscularly and/or three oral doses of garlic
pearl oil (50, 100, 150 mL/mouse on Day 3, 4 and 5) to non-an-
esthetized mice as shown in Table 1. Blood was drawn from tail
vein to check the parasitemia progression or inhibition at regular
time intervals and mouse mortality was noted daily by staining
blood smears with Giemsa. In vivo antimalarial activity was ex-
amined in groups of 10 male mice in three independent
experiments.
2.3. Serum sample preparation
Blood was collected from mice on different days of post infec-
tion and treatment by cardiac puncture and allowed to clot for
2 hours at room temperature. The clotted material was removed
by centrifugation at 5000 rpm for 15 minutes. The obtained serum
was stored at 80 °C in 100 mL aliquots until further analysis.
2.4. Analysis of parasite speciﬁc Immunoglobulin G (IgG) responses
by ELISA
Soluble parasite proteins were prepared as described by Ang
[34]. The parasite pellet was suspended in an appropriate volume
of PBS followed by sonication (5 min at 4 °C) and centrifugation at
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used to estimate parasite-speciﬁc IgG by ELISA. 10 μL of the su-
pernatant was coated onto 96-well ELISA plates (4 °C over night)
and reacted with 1:10 diluted serum in a total volume of 100 μL.
After carrying out the blocking and washing steps, 50 μL of sec-
ondary goat anti-mouse IgG-peroxidase conjugate (Bangalore
GeNei™, India) at 1:3000 dilution was added per well and color
developed with ABTS substrate was measured at 405 nm using an
ELISA plate reader.
2.5. SDS-PAGE and western blot analyses
Parasite proteins (100 μg) were separated by SDS-PAGE and
blotted onto nitrocellulose membranes. Membranes were cut in
vertical strips, blocked and incubated with individual serum
samples diluted 1:50 in PBS, pH 7.4. Antibody responses were
revealed with monoclonal secondary antibodies in dilution of
1:1000 followed by incubation with AP-conjugated anti-mouse
antibodies (Dako, Hamburg, Germany). Western blots were per-
formed with SDS-PAGE gels; all loaded with the same protein
preparation (100 μg) and run under identical electrophoretic
parameters. The strips shown originate from a single blot.
2.6. Statistical analysis
Log rank test was used for analysis of survival curves. All cal-
culations were performed on the Prism 5.0 statistical program
(GraphPad Software, San Diego, CA, USA). A value of Po0.05 was
considered signiﬁcant.3. Results and discussion
As shown in Figs. 1 and 2a, untreated mice died within 4–6
days post infection as the parasitemia increased consistently. In
contrast, administration of 50 mL/mouse of garlic pearl oil resulted
in the survival of animals up to Day 8 (20%). However, increase in
the administration volume of garlic pearl oil to 100 and 150 mL/
mouse did not result in extension in survival period as compared
to group treated with 50 mL/mouse garlic pearl oil. But percentage
of mice survived up to Day 8 increased from 20% to 60 and 70%
in case of 100 and 150 mL/mouse garlic pearl oil treated mice, re-
spectively (Fig. 2b). Though the data from the garlic monotherapy
is encouraging, all animals died of malaria infection with little
resistance compared to untreated mice group. Later α-β arteether,
a synthetic derivative of artemisinin, was chosen as the partner
drug for garlic pearl oil. Initially, the effect of arteetherFig. 1. Survivability of P.berghei-infected mice after treatment with garlic oil and/or
arteether. Survival curves were generated from three independent experiments
with a total of 10 mice per group. AE, arteether; G, garlic pearl oil.monotherapy on parasitemia progression and mortality was stu-
died. Treatment of infected mice with arteether at 750 mg/mouse
resulted in the initial clearance of parasitemia, but all animals died
of malaria infection between Day 18 and 21 (Fig. 2c and d).
However, treatment of mice with 1.5 mg of arteether resulted in
complete protection of animals from malaria infection for the
study duration in terms of mortality, parasitemia progression and
recrudescence (Fig. 2f). Further, to study the effect of combination
therapy, infected animals were treated with both arteether (single
dose) and garlic pearl oil (three doses). As shown in Fig. 1, treat-
ment with 50 mL/mouse garlic pearl oil and 750 mg of arteether
resulted in enhanced protection. In this combination treated
group, 100% of animals survived up to Day 19 and they succumbed
to malaria infection between Day 19 and 22.
Interestingly, increasing the garlic pearl oil quantity from 50 mL/
mouse to 100 or 150 mL/mouse in combination with α-β arteether
at 750 mg resulted in complete protection of animals from malaria
infection (Fig. 2e). These results clearly indicate that by adding
garlic pearl oil to arteether therapy as a partner drug antimalarial
activity can be enhanced. Particularly this combination was suc-
cessful in avoiding the recrudescence problem which is often the
major limiting factor in artemisinin and its derivative based
monotherapy as shown in our study (Fig. 2d) and earlier clinical
trials [31]. Although the exact mechanism of action is not clear yet,
from earlier studies it can be presumed that when infected mice
were given suboptimal dose of arteether, it will clear the parasite
quickly from the blood (erythrocytic stage) and garlic pearl oil,
which mainly composes of cysteine protease inhibitors and thio-
sulﬁnate products (Diallyl disulﬁde, Diallyl trisulﬁde, Allyl methyl
trisulﬁde etc), may have evaded infection of new blood cells by
inhibiting cysteine protease enzyme which is essential for the
invasion of malaria parasites to new red blood cells. In addition,
garlic pearl oil may have decreased the parasite load from the
reservoirs such as liver and spleen leading to reduced sporozoite
infectivity which in turn will clear the pre-erythrocytic parasites as
observed in earlier studies [32]. Adding to this, garlic pearl oil
treatment may elicit innate and adaptive immunity which are
shown to be useful in eradicating the parasites and to avoid the
recrudescence of malaria parasites [29]. Studies have also shown
similar immunomodulatory effect of another well known natural
compound curcumin in malaria infected mice [33].
To know the immunomodulatory role of the existing combi-
nation therapy, we studied the levels of parasite speciﬁc im-
munoglobulin (IgG) with different drug treatments to parasite
infection.
IgG concentrations were measured using ELISA in order to
determine the level of humoral immune response provoked in the
P. berghei-infected mice due to drug treatment [34]. AE and garlic
combination therapy resulted in a striking increase in anti-parasite
antibody IgG contributing protective immunity during the re-
crudescence phase (Fig. 3). These results correlate with western
blot analysis, where sera from the recrudescence stage and later
period of arteether and garlic pearl oil combination treated ani-
mals found to interact with several parasite speciﬁc proteins as
compared to the controls (Fig. 4).
The above observation suggests that there is growing evidence
concerning the protective role of IgG in malaria infections and also
demonstrates a differential parasite antigen reactivity of IgG re-
sponse acquired by host against malaria infection. This has been
carried out using ELISA and western blot analysis, which are the
conventional approaches widely used to study host immune re-
sponse against malaria antigens. At later period of time (after 90
days), when the antibody titre went down, fresh parasite injection
(Figs. 3 and 4) lead to increase in the levels of IgG, showing the
previous observation of animals. Our data support studies that
showed mice once cured of parasite infection remain completely
Fig. 2. Photomicrographs of blood smears showing the effect of different treatments on parasite growth with reference to control group. (A) Control on Day 5. (B) Garlic oil
150 mL/mouse on Day 5. (C) AE 750 mg on Day 5. (D) Recrudescence in AE 750 mg treated on Day 21. (E) AE 750 mgþgarlic oil 100 mL on Day 21 (F) AE 1.5 mg on Day 21.
Photographs were taken at 100X magniﬁcation.
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It is known that for cystic ﬁbrosis one garlic capsule has been
taken daily for eight weeks; for Helicobacter pylori infection, allicin
(the main ingredient in garlic) has been taken daily in combination
with standard treatment orally for 14 days and is non-toxic. Ad-
ditionally, Kyolic aged garlic extract plus steam-distilled garlic oil
taken orally, daily twice, for seven years have showed no toxic
effect [36]. These results have shown that garlic extract has no side
effects or toxicity in human.
The exact mechanism(s) of garlic as an antimalarial drug is not
clear. However, allicin has proven antimicrobial activity and also
active against protozoan parasites including Plasmodium, where it
is thought to be mediated by inhibiting cysteine proteases [37].
There are several reports of combination of garlic extracts with
antibiotics [38] and also known for its antituberculor activity [39].Protection of P. berghei-infected mice from early death by allicin
through immunomodulation has also been documented [32,40].4. Conclusions
The arteether and garlic pearl oil combination may prove su-
perior from several perspectives. Both are herbal medicines of long
term use, as such no resistance is known to garlic that's used as a
dietary supplement. The results of this study are encouraging, as
the most available artemisinin combination therapies suffer from
one or the other drawbacks such as toxicity, high cost, resistance
etc. The study shows that arteether and garlic pearl oil combina-
tion therapy provides complete protection in P. berghei-infected
mice. This seems promising in terms of addressing some of the
Fig. 3. Parasite speciﬁc Immunoglobulin G (IgG) responses from sera of different
treatments of P. berghei-infected mice by ELISA. The data represent Mean with SEM
from three different experiments.
1 2   3 4 5  6  
Fig. 4. Western blot analysis of parasite proteins with different treatments of P.
berghei-infected mice 1, Uninfected; 2, Infected (D5); 3, AE (D21); 4, AEþGarlic
(D21); 5, AEþGarlic before challenge (D90); 6, AEþGarlic after challenge (D90).
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and cost of therapy. In view of the above vision, further studies to
identify and characterize speciﬁc pathways involved in the me-
chanism of the action of artemisinin and garlic oil combination
therapy would be beneﬁcial in developing low-cost antimalarial
drug therapies, especially for drug resistant malaria.Acknowledgments
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